ISSN: 2538-4422

Journal Home

Journal Guideline

International Journal of Cancer Management Q3 Unclaimed

Brieflands Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Cancer Management is a journal indexed in SJR in Oncology and Cancer Research with an H index of 26. It has an SJR impact factor of 0,198 and it has a best quartile of Q3. It has an SJR impact factor of 0,198.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology (medical) (Q3) Surgery (Q3) Cancer Research (Q4) Oncology (Q4) Radiology, Nuclear Medicine and Imaging (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

International Journal of Cancer Management

0,198

SJR Impact factor

26

H Index

61

Total Docs (Last Year)

254

Total Docs (3 years)

1829

Total Refs

142

Total Cites (3 years)

247

Citable Docs (3 years)

0.54

Cites/Doc (2 years)

29.98

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cancer Management and Research Q3
Journal of Breast Cancer Q3
Breast Cancer: Basic and Clinical Research Q3
Oncology Letters Q3
Clinical Medicine Insights: Oncology Q3

Compare this journals

Aims and Scope

Best articles by citations

Intracyctic Papillary Carcinoma of the Breast: Report of a Rare Case and Literature Review

The Prediction of Colorectal Cancer Screening Based on the Extended Parallel Process Model: Moderating the Role of Health Literacy and Cancer-Related Empowerment

Non-Metastatic Basaloid Squamous Cell Carcinoma of the Uterine Cervix in a Woman with History of Subtotal Hysterectomy

Comparison of Early and Late Complications in Three Esophagectomy Techniques

A Case Report of Diffuse Large B-cell Lymphoma Masquerading as Necrotizing Lymph Nodes: The Role of Core Needle Biopsy for Early Diagnosis

Antisense Non-Coding RNA in the INK4 Locus (ANRIL) in Human Cancers

The Validation of Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI) Among Iranian Women with Breast Cancer

Epidemiological Evaluation of Palatal Cancers in Iran: A Study on 303 Cases

Evaluation of Involvement of Axillary Lymph Nodes with Ki-67 Expression in Patients with Breast Cancer

Influence of Preoperative Magnetic Resonance Imaging in Surgical Planning for Breast Cancer

Solitary Neaurofibroma in Lower Extremity with Central Extensive Hyalinization

Endometriosis: A Rare Cause of Gross Hematuria

SHOW MORE ARTICLES

Enhanced Anti-Cancer Capability of Ellagic Acid Using Solid Lipid Nanoparticles (SLNs)

Evaluation of the Gene Expression of Hedgehog Signaling Pathway Components in Response to Quinacrine in MDA-MB 231 Cells

Studying the Relation between Mental Adjustment to Cancer and Health-Related Quality of Life in Breast Cancer Patients

Leydig Cell Tumor in a 53-Year-Old Patient with Gynecomastia and Gynecodynia: A Case Report and Literature Review

A Case Report of Paraganglioma: A Diagnosis Not to Be Missed

The Radioprotective Effects of Nano-Curcumin Against Genotoxicity Induced by Iodine-131 in Patients with Differentiated Thyroid Carcinoma (DTC) by Micronucleus Assay

Pros and Cons of Intraoperative Radiotherapy: Comparison of Two Clinical Trials in Breast Cancer Management

Does the Novel Class of (2R, 4S)-N-(2, 5-Difluorophenyl)-4-Hydroxy-1-(2, 2, 2-Trifluoroacetyl) Pyrrolidine-2-Carboxamide's Have Any Effect on Cell Viability and Apoptosis of Human Hepatocellular Carcinoma Cells?

Outcomes of Breast Cancer (Invasive Lobular and Ductal Carcinoma) Treated with Boost Intraoperative Electron Radiotherapy Versus Conventional External Beam Radiotherapy

Brain Metastases in a 12-Year-Old Girl with Osteosarcoma: A Case Report

Cancer Incidence Rate in the Elderly Inhabitants of Tehran: Is there Really any Cluster?

Effects of Viral Peptide Presentation on CD4+ T Cell Responses to MHC Class II-Restricted Tumor Peptides